ADMA Biologics ADMA Other Income - Net
Other Income - Net at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's other income - net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's other income - net?
- ADMA Biologics (ADMA) reported other income - net of -$1.15M in Q1 2026.
- How has ADMA Biologics's other income - net changed year-over-year?
- ADMA Biologics's other income - net increased by 19.8% year-over-year, from -$1.43M to -$1.15M.
- What is the long-term trend for ADMA Biologics's other income - net?
- Over 2 years (2023 to 2025), ADMA Biologics's other income - net has grown at a -58.0% compound annual growth rate (CAGR), from -$49.87M to -$8.79M.
- What does other income - net mean?
- Includes gains or losses from activities outside the company's primary business, such as currency fluctuations, asset sales, or legal settlements. This metric helps isolate the impact of non-core events on the overall net income.